Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Nexium

Nexium
In stock
20mg · 40mg
from A$44.52
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$44.52
A$1.48 per tablet

In brief

  • In our pharmacy, you can buy nexium without a prescription (20 mg OTC in many regions) and we can supply prescription strengths where required; delivery available across Australia with discreet packaging.
  • Nexium (esomeprazole) is used to treat GERD, erosive oesophagitis, peptic ulcers (including as part of H. pylori eradication), Zollinger–Ellison syndrome and to reduce NSAID‑associated ulcer risk; it is a proton pump inhibitor that suppresses gastric acid secretion by blocking the H+/K+ ATPase in stomach parietal cells.
  • Usual adult doses are 20–40 mg once daily for GERD (20 mg for maintenance); H. pylori regimens typically use 20 mg twice daily with antibiotics; Zollinger–Ellison often starts at 40 mg twice daily and is titrated as needed.
  • Available as oral film‑coated tablets (10, 20, 40 mg), gastro‑resistant granules for oral suspension or feeding tubes (10 mg), and IV powder for infusion (40 mg vial); there is also a combo tablet with naproxen (Vimovo).
  • Esomeprazole begins to reduce stomach acid within about 1 hour, but noticeable symptom relief may take 1–4 days and is not for immediate relief of heartburn.
  • The duration of acid suppression is roughly 24 hours per dose; maximal acid control and symptom improvement occur with daily dosing over several days.
  • Avoid excessive alcohol while taking nexium as alcohol can worsen reflux and gastric irritation; there is no major direct interaction but moderation is advised and discuss alcohol use if you have liver disease.
  • The most common side effects include headache, diarrhoea, nausea, abdominal pain and flatulence; long‑term use can be associated with low magnesium, increased fracture risk and risk of C. difficile infection in susceptible people.
  • Would you like to try nexium without a prescription?

Basic Nexium Information

  • INN (International Nonproprietary Name): Esomeprazole
  • Brand Names Available In Australia: Nexium; Nexium Control (OTC format in some regions); Vimovo (combination esomeprazole/naproxen formulations may be available in some markets); various generics sold under local labels such as Esomeprazole Krka, Esopral and other country brands.
  • ATC Code: A02BC05
  • Forms & Dosages: Tablets film-coated 10 mg, 20 mg, 40 mg; Gastro-resistant granules 10 mg for paediatric/feeding tube use; IV powder for infusion 40 mg vial; combination tablet (Vimovo) 20/375 mg and 20/500 mg with naproxen.
  • Manufacturers In Australia: AstraZeneca (original brand developer) and multiple generics supplied by companies such as Sandoz, Mylan and other national suppliers; local availability varies by pack and strength.
  • Registration Status In Australia: Esomeprazole is registered in many countries worldwide and some 20 mg preparations have OTC status in parts of the world; check the ARTG entry for specific Australian registrations.
  • OTC / Rx Classification: Most strengths and indications are Prescription (Rx) only; some regions (including parts of Australia in certain pack sizes/strengths) may have 20 mg OTC short-term heartburn formats like “Nexium Control” or “Esomeprazole Control”.

Critical Warnings & Restrictions

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Who Needs Extra Caution?

  • Elderly people and frail older adults due to higher fracture and infection risks with long-term proton pump inhibitor use.
  • Pregnant or breastfeeding people — confirm pregnancy or lactation status before supply where relevant and document counselling.
  • People with chronic hepatic impairment, especially severe liver disease (Child‑Pugh C), where daily dose should generally be limited to 20 mg.
  • Anyone with a history of Clostridium difficile infection or conditions that increase GI infection risk.
  • People with previous allergic reactions to esomeprazole, omeprazole or other PPIs.

Absolute Contraindication

  • Known hypersensitivity to esomeprazole, omeprazole or other proton pump inhibitors is an absolute contraindication.

Pharmacy Screening Checklist At Point Of Supply

  • Confirm pregnancy and breastfeeding status where applicable.
  • Obtain a current medicines list including antiplatelets, anticoagulants and high‑dose methotrexate.
  • Ask about recent fractures and osteoporosis risk factors.
  • Record any past history of severe diarrhoea or C. difficile infection.
  • Check recent renal and hepatic function results when available.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Esomeprazole and other PPIs are not classically sedating.

Rare adverse effects such as dizziness, drowsiness or confusion can occur and may impair the ability to drive or perform safety‑critical tasks.

Advise patients in safety‑sensitive roles (driving, heavy machinery, safety‑sensitive work) to avoid those duties if they feel unwell after starting therapy.

Document counselling and the patient’s stated understanding in clinical notes for workplace safety audits and medicolegal records.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: Usually yes, but do not drive if you feel dizzy, drowsy or confused.

Safety‑critical workers should follow their employer, health surveillance and TGA guidance and local workplace health rules.

Usage Basics

INN, Brand Names Available In Australia

INN → Esomeprazole.

ATC → A02BC05.

Common brand names encountered include Nexium and multiple generics supplied by manufacturers such as AstraZeneca, Sandoz and Mylan.

Some pack formats called “Nexium Control” or “Esomeprazole Control” are sold OTC in certain regions as short‑term 20 mg packs; availability in Australia varies by pack and strength.

Legal Classification (TGA‑Approved, PBS‑Listed)

  • TGA: Esomeprazole is a TGA‑registered proton pump inhibitor for GERD, erosive oesophagitis, peptic ulcers including H. pylori regimens, Zollinger‑Ellison syndrome and NSAID‑ulcer risk reduction.
  • PBS: Certain indications, pack sizes and formulations may attract PBS subsidy; PBS listing depends on indication and prescribing rules, so check the current PBS schedule for eligibility and quantity limits.

Likely Prescription Versus OTC Scenarios

  • Higher strengths (40 mg) and hospital IV formulations are prescription only.
  • Some 20 mg short‑course tablets may be available OTC in selected pack sizes or under pharmacist supervision in parts of Australia.

Table Placeholder — TGA Versus PBS Actions

Dosing Guide

Standard Regimens (PBS Reference Dosing)

GERD and erosive oesophagitis: 20–40 mg once daily for 4–8 weeks to heal lesions.

Maintenance therapy for reflux: typically 20 mg once daily.

H. pylori eradication: 20 mg twice daily with appropriate antibiotics for 7–14 days.

Zollinger‑Ellison syndrome: start at 40 mg twice daily and titrate according to acid output and clinical response.

Table Placeholder — Condition — Usual Dose — Typical Duration

Adjustments For Comorbidities

  • Children: Use gastro‑resistant granules or lower strength tablets (10–20 mg) and dose by weight/age (children 1–11 years and >10 kg commonly 10–20 mg once daily).
  • Elderly: No routine dose reduction but monitor for long‑term PPI risks such as fractures, hypomagnesaemia and infections.
  • Hepatic impairment: In severe hepatic impairment (Child‑Pugh C) limit dose to a maximum of 20 mg daily.
  • Renal impairment: No routine adjustment required, but exercise caution in severe renal dysfunction and monitor comorbid therapy.

Prescriber Checklist

  • Confirm indication and target duration (short course vs maintenance).
  • Check hepatic function and consider 20 mg daily in severe impairment.
  • Review other medicines for interactions (clopidogrel, warfarin, methotrexate, protease inhibitors).
  • Plan monitoring (magnesium, B12) for long‑term use.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless the next dose is due soon.

Do not double up doses to catch up.

For short‑term OTC 20 mg courses, simply resume the usual schedule.

Seek advice if several doses are missed or if an overdose is suspected — large overdoses require symptomatic and supportive care.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Esomeprazole is most effective when taken before meals; take tablets 30–60 minutes before a main meal for best acid suppression timing.

Relief is not immediate and may take days to achieve full benefit, so counselling on expectations is important.

Alcohol can worsen reflux symptoms even when on a PPI, so advise moderation for symptom control.

Coffee, spicy and acidic foods may continue to trigger reflux and heartburn despite adequate PPI therapy.

Practical Meal Timing And Lifestyle Tips

  • Take esomeprazole 30–60 minutes before the main meal of the day when once‑daily dosing is used.
  • Avoid large meals, late‑night eating and excess alcohol to reduce breakthrough symptoms.
  • Advise weight management, head‑of‑bed elevation and smoking cessation as adjunct measures.

Common Drug Conflicts

Notable interactions include antiplatelet prodrugs and anticoagulants and agents dependent on gastric pH or CYP metabolism.

Specific interactions to watch for include clopidogrel (possible reduced activation), warfarin (monitor INR), some systemic antifungals and HIV protease inhibitors, and high‑dose methotrexate.

Long‑term PPI use may reduce absorption of vitamin B12 and magnesium, so consider monitoring serum levels when therapy is prolonged.

Table Placeholder — Drug — Interaction — Practical Action

Monitoring Checklist

  • Monitor INR when warfarin is co‑prescribed and counsel patients to report signs of bleeding.
  • Check serum magnesium and replace if low for long‑term users or if symptomatic.
  • Consider B12 testing with prolonged therapy and unexplained anaemia or neuropathy.

User Reports & Trends (Australian Patient Feedback)

Where Do We Hear From Patients?

Feedback comes from ProductReview, pharmacy counselling notes and local health forums in Australia.

Common themes reported by Australian patients include effective symptom relief for moderate to severe reflux and healed oesophagitis in many cases.

Typical patient concerns are price, access in rural areas and worries about long‑term safety such as bone health and infections.

Pros Noted By Users

  • Reduced frequency of reflux episodes and improved sleep for night‑time reflux.
  • Mucosal healing reported in patients with erosive disease after several weeks of treatment.

Cons Noted By Users

  • Occasional headaches or diarrhoea early in therapy.
  • Concerns about long‑term risks like fractures and C. difficile with chronic use.

Pharmacist Adverse‑Event Capture Checklist

  • Record onset, severity and whether symptoms resolved after stopping (dechallenge).
  • Note any rechallenge outcomes if the medicine was restarted.
  • Report serious or unexpected events to the TGA adverse event system as required.

Table Placeholder — Frequency Of Reported Effects

Rural patients report access and cost issues more frequently than urban patients, while urban patients more often comment on quick pharmacy access and brand choice.

Access & Purchase Options Australia

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Large national chains commonly stock prescription esomeprazole and, where OTC 20 mg packs are registered locally, may sell those as pharmacist‑only or OTC items.

Price sensitivity is high; many shoppers compare brand Nexium versus generic esomeprazole and choose generics for cost savings.

Loyalty programmes, multi‑buy deals and private label generics influence customer choice and perceived value.

Comparison Table Placeholder — Chain — Typical Availability — In‑Store Pickup — Private Script Vs PBS

Online Pharmacies And Telehealth E‑Prescriptions

Telehealth consultations with prescribers and electronic prescribing are widely used in Australia, allowing e‑prescriptions to be sent directly to a pharmacy for dispensing.

Online pharmacies offer home delivery, but verify the pharmacy is properly registered and that supplied products are TGA‑approved in Australia where applicable.

In our online pharmacy, nexium is available without a prescription, with discreet delivery to Australia in 9-21 days.

Verification Steps For Safe Online Purchase

  • Check the pharmacy’s Australian registration and TGA listing where relevant.
  • Confirm the seller will accept a valid prescription or that the product is a legally supplied OTC pack.
  • Verify the e‑prescription matches the medicine and pack size ordered.

Safe Online Purchase Checklist

  • Confirm pharmacy and prescriber credentials.
  • Check product packaging details (strength, expiry, batch number on receipt).
  • Keep documentation of consultation and prescription for follow up.

Mechanism & Pharmacology

Simplified Explanation

Esomeprazole is a proton pump inhibitor that irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, reducing gastric acid secretion.

The ATC classification is A02BC05, placing esomeprazole among drugs for acid‑related disorders and within the proton pump inhibitor subgroup.

As a PPI, esomeprazole provides potent acid suppression compared with H2 receptor antagonists in many clinical settings.

Clinical Terms

Onset of symptom relief is not immediate for most patients and often develops over days; mucosal healing of erosive disease may take weeks.

Formulations include oral tablets, gastro‑resistant granules for paediatric or feeding‑tube use and IV 40 mg vials for hospital use in severe cases.

Formulation choice depends on clinical need – oral tablets for community therapy, granules for children or patients with swallowing difficulty, and IV for severe bleeding ulcer or perioperative use.

Formulation Pros/Cons

  • Oral tablets: convenient, most common for community use.
  • Gastro‑resistant granules: suitable for paediatrics and feeding tubes; dose‑adjustable by weight.
  • IV powder: reserved for hospital use and severe cases; requires appropriate monitoring and administration facilities.

Diagram/Table Placeholder — Oral Vs IV Use

Indications & Off‑Label Uses

Approved Indications By TGA

  • Gastro‑oesophageal reflux disease (GERD) and erosive oesophagitis.
  • Duodenal and gastric ulcers, including use in Helicobacter pylori eradication regimens alongside antibiotics.
  • Zollinger‑Ellison syndrome and other hypersecretory states.
  • NSAID‑associated ulcer risk reduction during concomitant NSAID therapy.

Table Placeholder — Indication → Typical Dose

Off‑Label Uses In Australian Clinical Practice

Off‑label uses may include short trials for refractory dyspepsia where other measures fail, stress‑ulcer prophylaxis in selected hospital settings and symptom control while investigating other causes.

When prescribing off‑label, document the clinical rationale and discuss the evidence and alternatives with the patient.

Prescriber Off‑Label Checklist

  • Summarise relevant evidence and guideline support for the off‑label use.
  • Define intended duration and monitoring parameters before starting therapy.
  • Obtain and document informed consent and provide written patient information.

Key Clinical Findings 2022–2026 Summary

Recent systematic reviews and meta‑analyses continue to show that proton pump inhibitors provide superior healing rates for erosive oesophagitis compared with H2 receptor antagonists.

Esomeprazole is effective as part of H. pylori eradication regimens when combined with appropriate antibiotics at recommended dosing (20 mg twice daily typical).

Observational data from 2022–2026 continue to associate long‑term PPI use with modestly increased risks of C. difficile infection, hypomagnesaemia, decreased vitamin B12 levels and an increased risk of fractures, especially in elderly or frail patients.

Clinical application: use the lowest effective dose for the shortest duration required and review the ongoing need for therapy every 6–12 months.

Key Outcomes

  • Efficacy: high rates of symptom control and mucosal healing in erosive disease.
  • Safety signals: infection risk (C. difficile), electrolyte disturbances (low magnesium), B12 deficiency and fracture risk with chronic exposure.

Table Placeholder — Major Endpoints Vs Monitoring Actions

Apply national guidance such as RACGP principles and NHMRC recommendations when reviewing long‑term acid suppression therapy.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Alternative proton pump inhibitors commonly used in Australia include omeprazole, pantoprazole, lansoprazole and rabeprazole.

Table Placeholder — Drug — Common Strengths — PBS Status — Key Pros/Cons

Pros And Cons Checklist

  • Pros of switching to generics: lower cost and similar efficacy to the original brand for most patients.
  • Cons: small pharmacokinetic differences and patient perception of effectiveness may vary.
  • Consider interaction profiles; for example omeprazole has raised concern with clopidogrel activation in some studies.
  • Evaluate cost, comorbidity, interactions, renal/hepatic status and patient preference when choosing an alternative.

Common Questions

Here are common pharmacy queries and short scripts useful at the counter.

  • “How long until it works?” — Symptom improvement often takes several days; mucosal healing for GERD typically requires 4–8 weeks.
  • “Can I stop suddenly?” — Stopping is generally safe but rebound acid hypersecretion can occur; consider step‑down or on‑demand use for mild intermittent symptoms.
  • “Is it safe long term?” — Long‑term use requires monitoring for bone health, magnesium and B12; reassess ongoing need regularly.
  • “Is generic as good as Nexium?” — Generics contain the same active ingredient esomeprazole and are bioequivalent; discuss subsidy savings when appropriate.

Quick Counselling Scripts

  • “Take this 30–60 minutes before your main meal each day for best effect.”
  • “If you get new severe diarrhoea or unexplained weakness, come back for review.”
  • “We’ll check with your GP if you need ongoing therapy beyond a few months.”

Red Flags Prompting GP/Specialist Referral

  • Dysphagia, unintentional weight loss, melaena or persistent vomiting.
  • New anaemia, recurrent severe diarrhoea or signs suggestive of serious GI disease.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Table Placeholder — Chemist Warehouse, Priceline, TerryWhite Chemmart, Online Pharmacies, Hospital (IV)

Note: Prices vary; check local listings and the PBS schedule for up‑to‑date subsidised pricing and eligibility criteria.

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Check PBS eligibility and the specific indication required for subsidy.
  • Consider generic substitution to reduce out‑of‑pocket costs.
  • Confirm acceptance of e‑prescriptions and plan for possible rural delivery delays.
  • Use pharmacist counselling to confirm dose, timing and follow up arrangements for people in remote areas.

Registration & Regulation

TGA Approval

Esomeprazole is TGA‑registered for acid‑related disorders with available formulations including tablets, gastro‑resistant granules and IV powder for infusion 40 mg vials used in hospital settings.

Always confirm the specific registered indication and dosage by checking the ARTG entry before prescribing or supplying for an unlisted indication.

PBS Subsidy Details

PBS subsidy depends on the indication, pack size and prescribing authority and some strengths/uses are more likely to attract reimbursement.

OTC availability of 20 mg packs in other countries does not guarantee PBS coverage in Australia.

Checklist For Clinicians

  • Check the ARTG to confirm the registered formulation and indication.
  • Look up the PBS schedule to determine subsidy eligibility for the patient’s indication.
  • Document the clinical rationale when prescribing off‑label or requesting authority for PBS listing.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Store tablets at room temperature in a dry place below 25°C and protect from humidity common in many Australian homes.

Keep granules in their original sachets until use and avoid storing medicines in bathrooms or near sinks.

Advise patients to keep medicines out of reach of children and to retain original packaging for batch and expiry information.

Cold‑Chain Handling For Pharmacies

IV vials and certain special formulations should be stored as per manufacturer instructions and must not be frozen.

Pharmacies should maintain SOPs for storage, keep temperature logs and ensure transport procedures include protection from heat and moisture for regional distribution.

Pharmacy SOP Checklist

  • Maintain temperature logs and batch recall traceability documents.
  • Follow manufacturer storage instructions for IV vials and monitor transport conditions for deliveries to remote sites.

Guidelines For Proper Use

Australian Pharmacist Counselling Style

Open with the patient’s main concern and explain the purpose of esomeprazole: acid suppression for symptom relief and healing where needed.

Explain the expected time to effect (days for symptom relief, weeks for mucosal healing) and the correct timing (usually 30–60 minutes before a main meal).

Cover missed dose guidance, common side effects such as headache and diarrhoea, and highlight red flags requiring medical review.

Standard Counselling Checklist

  • Indication, dose and duration to be taken.
  • Timing relative to meals and missed dose instructions.
  • Common side effects and when to seek help.
  • Plan for GP review if ongoing therapy is needed beyond initial course.

Short Script Template For Documentation

“Explained purpose, dosing (30–60 min before main meal), expected onset (days to weeks), side effects and red flags. Patient understood and accepted.”

Patient Advice From PBS And National Health Authorities

Use the lowest effective dose for the shortest necessary duration and arrange GP review if symptoms persist or PPI therapy is likely to be long term.

Monitor magnesium and vitamin B12 levels in patients on prolonged therapy and consider bone health assessment in the elderly or those with fracture risk factors.

Encourage reporting of adverse events to the TGA via the DAEN or through pharmacist adverse event systems.

Monitoring Intervals

  • Review therapy and need for continuation every 6–12 months for maintenance users.
  • Check electrolytes and magnesium if long‑term therapy or if symptomatic.
  • Consider B12 levels if prolonged therapy with anaemia or neuropathic symptoms.

Printable Patient Checklist

  • Indication, dose, duration and expected time to effect.
  • Common side effects and red flags to report.
  • Follow‑up review date or GP referral if symptoms persist.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 14-21 days
Wollongong New South Wales 14-21 days
Geelong Victoria 14-21 days
Cairns Queensland 14-21 days
Townsville Queensland 14-21 days
Toowoomba Queensland 14-21 days

Related products